In terms of appetite suppression onset, many patients report that tirzepatide produces noticeable effects slightly faster, likely due to its dual GIP/GLP-1 mechanism
He has a great demeanor that shows he really cares about his patients
The BMI requirements for GLP-1 prescriptions also play into military medical authorization decisions
In other words, neither Ozempic nor Mounjaro is likely to be covered for weight loss, but they could both be covered for Type 2 diabetes, because they are FDA approved for that use
Unfortunately, many individuals with type 2 diabetes fail to achieve the recommended glycaemic control target [3]
Emerging research is investigating whether lower maintenance doses might sustain weight loss while reducing cost and side effect burden, but this approach is not yet supported by randomized controlled trials and should only be undertaken with physician guidance